|
|||||
National Heart, Lung, and Blood Institute, or NHLBI, part of the National Institutes of Health is suspending a clinical trial of stem cells to regenerate new heart muscle. . . . → Read More: NIH Stops Stem Cell Heart Failure Trial Over Retracted Data  One comment - (Comments are closed)  Regulations  biomedical, biotechnology, clinical trials, heart disease, life sciences, NIH, pharmaceuticals, preclinical, stem cells, university 
Dicerna Pharmaceuticals, developing treatments for disease that silence genes by interfering with their RNA instructions, is licensing its technology to drug maker Eli Lilly and Co . . . → Read More: Gene Silencing Technology Licensed in $3.7B Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, genomics, investment, licensing, life sciences, pharmaceuticals 
The global chemical company BASF is licensing a more precise form of genome editing from the Broad Institute, a genetics research center affiliated with Harvard University and MIT. . . . → Read More: BASF Licensing Precise Crispr Editing from Broad Institute One comment - (Comments are closed) Intellectual property agriculture, biomedical, biotechnology, chemistry, Europe, genomics, licensing, manufacturing, patent, physical sciences, university 
Researchers in the U.K. created an antibiotic acid from a natural microbe found in soil, using a combination of the genome editing technique Crispr and bioinformatics. . . . → Read More: Genome Editing, Informatics Lead to New Antibiotic Comments are closed New products biomedical, biotechnology, chemistry, Europe, genomics, life sciences, pharmaceuticals, physical sciences, U.K., university 
A company in Maryland developing alternatives to human organ transplants is licensing a technology to help create 3-D printed lungs for transplantation with bioinks derived from tobacco plants. . . . → Read More: Licensing Deal for Bioinks in 3-D Printed Transplant Lungs One comment - (Comments are closed) Intellectual property, New products agriculture, biomedical, biotechnology, engineering, entrepreneurs, Israel, licensing, life sciences, materials science, medical device, physical sciences, university 
Drug maker AbbVie and biotechnology company Morphic Therapeutic are collaborating on new treatments for fibrosis based on Morphic’s technology blocking proteins that promote fibrosis. . . . → Read More: Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, licensing, life sciences, pharmaceuticals, preclinical, university 
A synthetic antibody is shown in tests with lab mice to block the blood protein fibrin from causing inflammation and related damage to brain cells found in neurodegenerative diseases. . . . → Read More: Antibody Designed to Stop Inflammation Protein in Brain Comments are closed New products biomedical, biotechnology, entrepreneurs, life sciences, pharmaceuticals, preclinical, university 
A document with standard legal language for terms and conditions of sharing biotechnology materials is now available for academic and industry research labs. . . . → Read More: Model Biotech Materials Sharing Agreement Unveiled Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, life sciences, NIH, standard, U.K., university 
Two clinical trials testing synthetic antibodies designed to treat blood-related cancers were stopped by their developer after a participant in one trial died from adverse effects. . . . → Read More: Cancer Antibody Trials Stopped After Patient Death Comments are closed Regulations biomedical, biotechnology, cancer, clinical trials, life sciences, pharmaceuticals 
Research with lab mice shows prenatal genome editing with techniques including Crispr can correct an inherited defect associated with a fatal congenital liver disorder. . . . → Read More: Prenatal Genome Edits Prevent Inherited Liver Disorder Comments are closed New products biomedical, biotechnology, genomics, life sciences, pharmaceuticals, preclinical, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
